Abattis Biologix Corporation - News - Wed Feb 22, 2012

Investors

2011 Annual Report >

News

Feb 21, 2012 Abattis Announces a Binding Letter Agreement with Animo Wellness Corporation VANCOUVER, British Columbia (February 21, 2012)---Abattis Biologix Corporation (CNSX: FLU) (the "Company") is pleased to announce that it has entered into a binding letter agreement (the " Letter Agreement ") with Animo Wellness Corporati...
Feb 17, 2012 Abattis Announces Cancellation of 10,250,000 Shares Pursuant to Termination of ZITEK Licensing Agreement February 17, 2012 -- Vancouver, British Columbia -- Abattis Biologix Corporation (the " Company " or " Abattis ") (CNSX: FLU) is pleased to announces that further to the termination of the Company's agreement with the Hensley Group I...
Feb 16, 2012 Abattis to sponsor and present in the 20th Annual Wellness Show and the launch of the worlds first painless Flu shot VANCOUVER, British Columbia (February 16, 2012)---Abattis Biologix Corporation (CNSX: FLU) (the "Company") is pleased to announce that it will sponsor and present in the 20th Annual Wellness Show, which will take place on 17, 18 & 19 of Februa...
Feb 15, 2012 Abattis Closes Second Tranche of Private Placement VANCOUVER, British Columbia (February 15, 2012)---Abattis Biologix Corporation (CNSX: FLU) (the "Company") is pleased to announce that further to its news release of December 11, 2011 and February 10, 2012, the Company has now completed the se...
Feb 06, 2012 Abattis Announces Grant of Stock Options and Shares for Debt Settlement Vancouver, BC - February 6, 2012 - Abattis Biologix Corporation (CNSX:FLU) ("Abattis" or the "Company") wishes to announce that it has negotiated a shares for debt settlement with a director of the Company in relation to a $49,000 debt owed to the di...
Jan 24, 2012 Abattis Terminates ZITEK Licensing Agreement VANCOUVER, British Columbia (January 24, 2012)---Abattis Biologix Corporation (CNSX: FLU) (the "Company") announces that it has today terminated its prior agreement with the Hensley Group Inc. dated October 8, 2010 pursuant to which it had bee...
Dec 11, 2011 Abattis Announces Private Placement Vancouver, BC - December 11, 2011 - Abattis Biologix Corporation (CNSX:FLU) ("Abattis" or the "Company") announces a non-brokered private placement offering of up to $240,00 ($200,000 + 20% optional maximum) through the sale of up to 4,800,000 units...
Dec 07, 2011 Abattis signs LOI to Acquire Sci-Naturals Wellness Corp. & Northern Vine Canada Inc. Abattis Biologix Corporation (CNSX: FLU) ("Abattis" or the "Company"), a specialty biotechnology company focused on developing, licensing and marketing a range of neutraceutical products, today announced that it has signed Letters of Intent ("LOI") w...
Dec 06, 2011 Abattis signs LOI to Acquire Nutra Research International Ltd. Abattis Biologix Corporation (CNSX: FLU) ("Abattis" or the "Company"), a specialty biotechnology company focused on developing, licensing and marketing a range of neutraceutical products, today announced that it has signed a Letter of Intent ("LOI") ...
Sep 13, 2011 Abattis Announces changes to the Board of Directors & Cancellation of Outstanding Debt Vancouver, BC - September 13, 2011 - Abattis Biologix Corporation (CNSX:FLU) ("Abattis" or the "Company") is pleased to welcome Mr. Yazan Alhomsi to company's Board of Directors. Mr. Alhomsi is a Manager of Financial Services for PricewaterhouseCoop...
Jun 17, 2011 Abattis Biologix Corporation Begins Trading on Pink Sheets Vancouver BC, June 17, 2011---Abattis Biologix Corporation (CNSX: FLU) announced today that their shares have commenced trading on the OTC Pink Sheets under the symbol ABBTF. Pink Sheet trading will provide shareholders with liquidity as the c...
Jun 06, 2011 ABATTIS CLARIFIES POSITION ON IP ACQUISTION FROM FORMER ZICAM(r) DEVELOPER Vancouver, BC June 6, 2011-Abattis Biologix Corporation (CNSX:FLU) announced today they have learned that the U.S. Government has charged Dr. Charles Hensley with unlawfully importing and distributing an unapproved herbal product named, "Vira ...
May 18, 2011 Abattis Biologix Appoints Natural Food and Nutrition Expert for Business Development, Corporate Communications and Brand Positioning Vancouver-May 18, 2011 -Abattis Biologix Corporation ("Abattis") (CNSX: FLU) engaged the services of a well-known natural food and products expert to develop new business opportunities and conduct multi-faceted media campaigns for its Immune So...
May 02, 2011 Abattis Acquires Exclusive Rights to Intellectual Property for New Wellness-Specific Formulas and Announces Changes to the Board of Directors VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 2, 2011) - Abattis Biologix Corporation (CNSX: FLU) ("Abattis" or the "Company") has concluded a series of meetings and negotiations culminating in the signing of a number of strategically importa...
May 01, 2011 Abattis Biologix Appoints Natural Food and Nutrition Expert for Business Development, Corporate Communications and Brand Positioning Vancouver---May 18, 2011---Abattis Biologix Corporation ("Abattis") (CNSX: FLU) engaged the services of a well-known natural food and products expert to develop new business opportunities and conduct multi-faceted media campaigns for its Immun...
Feb 01, 2011 Abattis Biologix Corporation Appoints New President & CEO Vancouver, BC - February 1, 2011 -- Abattis Biologix Corporation (CNSX:FLU) ("Abattis" or the "Company") is pleased to announce the appointment of Mr. Mike Withrow as President and Chief Executive Officer of the Company effective immediately. M...
Sep 17, 2009 Abattis Biologix Corporation Announces Share Consolidation VANCOUVER, BC -- September 17, 2009 -- Abattis Biologix Corporation (the "Company"), formerly Sican Ventures Inc., announces that effective immediately, the Company has consolidated its common shares on the basis of one (1) post-consolidation common ...